로딩 중…
지수 로딩 중…
DHP Korea Co., Ltd.
131030· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,710+0.71%
2026-09-18
Financials
Valuation Metrics
DHP Korea Co., Ltd.'s Market Cap is ₩1008B. At end of 2025 it was ₩1214B. Ranked #1279 of 2,421 in KR market (top 53%), #698 of 1,640 on KOSDAQ (top 43%), #46 of 96 in Health Care Equipment & Services (top 48%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 100.76B KRW | KR#1,279/2,421 Sec#46/96 |
| Revenue | 94.47B KRW | KR#1,447/2,421 Sec#41/96 |
| Net Income | 13.75B KRW | KR#850/2,421 Sec#23/96 |
| Total Assets | 191.06B KRW | KR#1,345/2,421 Sec#37/96 |
| Net Assets | 165.01B KRW | KR#1,074/2,421 Sec#28/96 |
| Employees | 239 | KR#954/2,421 Sec#28/96 |
| Value | ||
| P/E | 7.33x | KR#601/2,421 Sec#15/96 |
| P/B | 0.61x | KR#1,004/2,421 Sec#18/96 |
| PEG | 0.16x | KR#511/2,421 Sec#24/96 |
| P/S | 1.07x | KR#1,424/2,421 Sec#31/96 |
| EV/EBITDA | 7.93x | KR#468/2,421 Sec#16/96 |
| FCF Yield | -28.08% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | 8.33% | KR#758/2,421 Sec#31/96 |
| ROA | 7.20% | KR#498/2,421 Sec#25/96 |
| Op. Margin | 10.70% | KR#482/2,421 Sec#28/96 |
| Revenue Growth | 14.08% | KR#721/2,421 Sec#38/96 |
| Earnings Growth | 44.65% | KR#575/2,421 Sec#26/96 |
| Financial Health | ||
| Debt Ratio | 15.79% | KR#268/2,421 Sec#16/96 |
| Total Debt | 0 KRW | KR—/2,421 Sec—/96 |
| FCF | -28.29B KRW | KR#1,977/2,421 Sec#77/96 |
| Cash | 20.67B KRW | KR#1,236/2,421 Sec#32/96 |
| Current Ratio | 4.03x | KR#379/2,421 Sec#27/96 |
| Net Debt/EBITDA | -2.05x | KR#235/2,421 Sec#5/96 |
| Dividend | ||
| Div. Yield | 1.51% | KR#1,003/2,421 Sec#31/96 |
| Div. Growth | 0.62% | KR#685/2,421 Sec#24/96 |
| Performance | ||
| 1Y Return | -29.33% | KR#1,545/2,421 Sec#41/96 |
| 1M Return | -0.70% | KR#1,315/2,421 Sec#41/96 |
| From 52W High | -72.48% | KR#2,249/2,421 Sec#88/96 |
| 1Y MDD | -74.56% | KR#2,163/2,421 Sec#83/96 |
| Trading | ||
| Volume | 12,090 shares | KR#1,834/2,421 Sec#75/96 |
| Trading Value | 68.9M KRW | KR#1,714/2,421 Sec#66/96 |
| Foreign Own. | 3.96% | KR#1,057/2,421 Sec#34/96 |
| Per Share | ||
| EPS | 779 KRW | KR#817/2,421 Sec#18/96 |
| BPS | 9,351 KRW | KR#1,039/2,421 Sec#23/96 |
Company Info
동사는 2010년 설립되어 2013년 디에이치피코리아와 합병하고, 2022년 옵투스제약으로 상호변경함. 눈 건조, 감염 등 안과 질환 예방 및 치료에 초점을 맞춘 점안액을 전문적으로 개발·제조하며, 안과 분야 전문 기업임. 2024년 신규공장 건축공사 착수로 연간 생산능력을 2026년까지 확대할 예정이며, AOA 교육 플랫폼 도입과 KAM 적용으로 제품 인지도 제고 및 거래처 관리 효율성을 개선하고 있음. 옵투스제약는 2010년에 설립되었으며 충청북도 청주시에 본사를 두고 있습니다.